company background image
1652 logo

Fusen Pharmaceutical SEHK:1652 Stock Report

Last Price

HK$0.91

Market Cap

HK$703.6m

7D

-12.5%

1Y

-30.0%

Updated

28 Mar, 2024

Data

Company Financials

Fusen Pharmaceutical Company Limited

SEHK:1652 Stock Report

Market Cap: HK$703.6m

1652 Stock Overview

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People’s Republic of China.

1652 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Fusen Pharmaceutical Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Fusen Pharmaceutical
Historical stock prices
Current Share PriceHK$0.91
52 Week HighHK$1.60
52 Week LowHK$0.95
Beta0.28
1 Month Change-26.02%
3 Month Change-33.58%
1 Year Change-30.00%
3 Year Change-81.24%
5 Year Change-80.04%
Change since IPO-64.17%

Recent News & Updates

Recent updates

Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky

Dec 14
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky

Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly

Sep 02
Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly

Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly

Apr 02
Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly

A Look At Fusen Pharmaceutical's (HKG:1652) Share Price Returns

Mar 06
A Look At Fusen Pharmaceutical's (HKG:1652) Share Price Returns

We Wouldn't Rely On Fusen Pharmaceutical's (HKG:1652) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Fusen Pharmaceutical's (HKG:1652) Statutory Earnings As A Guide

Is Fusen Pharmaceutical Company Limited's (HKG:1652) Recent Price Movement Underpinned By Its Weak Fundamentals?

Jan 18
Is Fusen Pharmaceutical Company Limited's (HKG:1652) Recent Price Movement Underpinned By Its Weak Fundamentals?

Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?

Dec 28
Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?

What You Need To Know About Fusen Pharmaceutical Company Limited's (HKG:1652) Investor Composition

Dec 07
What You Need To Know About Fusen Pharmaceutical Company Limited's (HKG:1652) Investor Composition

If You Had Bought Fusen Pharmaceutical (HKG:1652) Shares A Year Ago You'd Have Earned 34% Returns

Nov 20
If You Had Bought Fusen Pharmaceutical (HKG:1652) Shares A Year Ago You'd Have Earned 34% Returns

Shareholder Returns

1652HK PharmaceuticalsHK Market
7D-12.5%-0.8%-0.6%
1Y-30.0%-11.4%-14.0%

Return vs Industry: 1652 underperformed the Hong Kong Pharmaceuticals industry which returned -11.4% over the past year.

Return vs Market: 1652 underperformed the Hong Kong Market which returned -14% over the past year.

Price Volatility

Is 1652's price volatile compared to industry and market?
1652 volatility
1652 Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement7.3%
10% most volatile stocks in HK Market14.6%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 1652's share price has been volatile over the past 3 months.

Volatility Over Time: 1652's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20031,121Dudu Caohttps://www.fusenyy.com

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People’s Republic of China. The company’s product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. It also researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia.

Fusen Pharmaceutical Company Limited Fundamentals Summary

How do Fusen Pharmaceutical's earnings and revenue compare to its market cap?
1652 fundamental statistics
Market capHK$703.59m
Earnings (TTM)-HK$12.03m
Revenue (TTM)HK$717.44m

0.9x

P/S Ratio

-56.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1652 income statement (TTM)
RevenueCN¥662.58m
Cost of RevenueCN¥338.18m
Gross ProfitCN¥324.41m
Other ExpensesCN¥335.52m
Earnings-CN¥11.11m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.015
Gross Margin48.96%
Net Profit Margin-1.68%
Debt/Equity Ratio46.8%

How did 1652 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.